期刊
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA
卷 26, 期 4, 页码 689-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.soc.2017.05.008
关键词
Colon cancer; Rectal cancer; Colorectal cancer; Surgery; Radiation; Chemotherapy; Adjuvant; Neoadjuvant
Surgery remains the mainstay of treatment for colon and rectal cancers. Colon cancer outcomes have improved with laparoscopic techniques, enhanced recovery pathways, and adjuvant chemotherapy. Adjuvant 5-fluorouracil with or without oxaliplatin in stage III and possibly high-risk stage II colon cancer is associated with improved survival., Multimodality management of rectal cancer continues to evolve; total mesorectal excision is the cornerstone. Oncologic results do not support the use of laparoscopic resection in rectal cancer. Preoperative short- or long-course radiation for stage II or III rectal cancer is the standard of care. Long course chemoradiation is recommended for bulky tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据